ES2570135T3 - Sal y solvatos de un derivado de tetrahidroisoquinolina - Google Patents
Sal y solvatos de un derivado de tetrahidroisoquinolinaInfo
- Publication number
- ES2570135T3 ES2570135T3 ES11740973T ES11740973T ES2570135T3 ES 2570135 T3 ES2570135 T3 ES 2570135T3 ES 11740973 T ES11740973 T ES 11740973T ES 11740973 T ES11740973 T ES 11740973T ES 2570135 T3 ES2570135 T3 ES 2570135T3
- Authority
- ES
- Spain
- Prior art keywords
- solvates
- salt
- tetrahydroisoquinoline derivative
- tetrahydroisoquinoline
- derivative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Sal de sodio del ácido (S)-2-(difenilacetil)-1,2,3,4-tetrahidro-6-metoxi-5-(fenilmetoxi)-3-isoquinolin-carboxílico y solvatos del mismo, en forma amorfa o en forma de un solvato cristalino.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36636710P | 2010-07-21 | 2010-07-21 | |
PCT/GB2011/001096 WO2012010843A1 (en) | 2010-07-21 | 2011-07-21 | Salt and solvates of a tetrahydroisoquinoline derivative |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2570135T3 true ES2570135T3 (es) | 2016-05-17 |
Family
ID=44386640
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES11740973T Active ES2570135T3 (es) | 2010-07-21 | 2011-07-21 | Sal y solvatos de un derivado de tetrahidroisoquinolina |
Country Status (19)
Country | Link |
---|---|
US (3) | US8614227B2 (es) |
EP (2) | EP3081557A1 (es) |
JP (3) | JP5948326B2 (es) |
CN (2) | CN103003244B (es) |
AU (3) | AU2011281381B2 (es) |
CA (1) | CA2803699C (es) |
DK (1) | DK2595960T3 (es) |
ES (1) | ES2570135T3 (es) |
HK (1) | HK1224290A1 (es) |
HR (1) | HRP20160540T1 (es) |
HU (1) | HUE028620T2 (es) |
ME (1) | ME02407B (es) |
NZ (2) | NZ605444A (es) |
PL (1) | PL2595960T3 (es) |
PT (1) | PT2595960E (es) |
SI (1) | SI2595960T1 (es) |
SM (1) | SMT201600171B (es) |
WO (1) | WO2012010843A1 (es) |
ZA (1) | ZA201300169B (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2595960T3 (en) * | 2010-07-21 | 2016-05-09 | Novartis Ag | Salt and solvates of a tetrahydroisoquinoline derivative |
US9320530B2 (en) * | 2013-03-13 | 2016-04-26 | The Spectranetics Corporation | Assisted cutting balloon |
US9714224B2 (en) | 2013-07-08 | 2017-07-25 | Novartis Ag | Heterocyclic compounds and methods of their use |
PL3245198T3 (pl) | 2015-01-13 | 2020-10-05 | Novartis Ag | Pochodne pirolidyny jako antagonisty angiotensyny ii typu 2 |
EP3268356B1 (en) | 2015-03-12 | 2021-08-25 | Novartis Ag | Heterocyclic compounds and methods for their use |
CN106478502B (zh) * | 2015-08-29 | 2021-04-27 | 上海翰森生物医药科技有限公司 | 1,2,3,4-四氢异喹啉衍生物、其制备方法和应用 |
US20190152918A1 (en) | 2016-06-27 | 2019-05-23 | Ratiopharm Gmbh | Crystalline calcium salt of (s)-2-(diphenylacetyl)-1,2,3,4-tetrahydro-6-methoxy-5-(phenylmethoxy)-3-isoquinoline carboxylic acid |
JP2019514862A (ja) * | 2017-03-23 | 2019-06-06 | ノバルティス アーゲー | (s)−2−(ジフェニルアセチル)−1,2,3,4−テトラヒドロ−6−メトキシ−5−(フェニルメトキシ)−3−イソキノリンカルボン酸ナトリウムの無水結晶形 |
CN110914243B (zh) * | 2017-06-09 | 2023-02-28 | 山东丹红制药有限公司 | 作为at2r受体拮抗剂的羧酸衍生物 |
WO2020012266A1 (en) | 2018-07-12 | 2020-01-16 | Novartis Ag | Biocatalytic synthesis of olodanrigan (ema401) from 3-(2-(benzyloxy)-3-methoxyphenyl)propenoic acid with phenylalanine ammonia lyase |
CA3105916A1 (en) | 2018-07-12 | 2020-01-16 | Codexis, Inc. | Engineered phenylalanine ammonia lyase polypeptides |
CN111620816B (zh) * | 2020-05-27 | 2023-06-02 | 上海赛默罗生物科技有限公司 | 螺桨烷类衍生物、其制备方法、药物组合物和用途 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5246943A (en) | 1992-05-19 | 1993-09-21 | Warner-Lambert Company | Substituted 1,2,3,4-tetahydroisoquinolines with angiotensin II receptor antagonist properties |
US5236934A (en) | 1992-08-26 | 1993-08-17 | E. I. Du Pont De Nemours And Company | 1,2,3,4-tetrahydroisoquinolines useful in the treatment of CNS disorders |
EP1059843A1 (en) * | 1998-02-25 | 2000-12-20 | Merck & Co., Inc. | Method for decreasing qt dispersion or inhibiting the progression of qt dispersion with an angiotensin ii receptor antagonist |
SI1830869T1 (sl) | 2004-12-24 | 2013-12-31 | Spinifex Pharmaceuticals Pty Ltd | Postopek zdravljenja ali profilakse |
CA2866540A1 (en) | 2006-03-20 | 2007-09-27 | Spinifex Pharmaceuticals Pty Ltd. | Method of treatment or prophylaxis of inflammatory pain |
NZ601383A (en) * | 2010-01-19 | 2014-07-25 | Spinifex Pharm Pty Ltd | Methods and compositions for improved nerve conduction velocity |
DK2595960T3 (en) * | 2010-07-21 | 2016-05-09 | Novartis Ag | Salt and solvates of a tetrahydroisoquinoline derivative |
-
2011
- 2011-07-21 DK DK11740973.0T patent/DK2595960T3/en active
- 2011-07-21 WO PCT/GB2011/001096 patent/WO2012010843A1/en active Application Filing
- 2011-07-21 PL PL11740973.0T patent/PL2595960T3/pl unknown
- 2011-07-21 NZ NZ605444A patent/NZ605444A/en not_active IP Right Cessation
- 2011-07-21 EP EP15200360.4A patent/EP3081557A1/en not_active Withdrawn
- 2011-07-21 CN CN201180035468.9A patent/CN103003244B/zh not_active Expired - Fee Related
- 2011-07-21 ES ES11740973T patent/ES2570135T3/es active Active
- 2011-07-21 EP EP11740973.0A patent/EP2595960B1/en active Active
- 2011-07-21 ME MEP-2016-98A patent/ME02407B/me unknown
- 2011-07-21 SI SI201130804A patent/SI2595960T1/sl unknown
- 2011-07-21 JP JP2013520203A patent/JP5948326B2/ja not_active Expired - Fee Related
- 2011-07-21 US US13/187,882 patent/US8614227B2/en not_active Expired - Fee Related
- 2011-07-21 PT PT117409730T patent/PT2595960E/pt unknown
- 2011-07-21 AU AU2011281381A patent/AU2011281381B2/en not_active Ceased
- 2011-07-21 CN CN201610152658.3A patent/CN105777636A/zh active Pending
- 2011-07-21 NZ NZ708529A patent/NZ708529A/en not_active IP Right Cessation
- 2011-07-21 HU HUE11740973A patent/HUE028620T2/en unknown
- 2011-07-21 CA CA2803699A patent/CA2803699C/en not_active Expired - Fee Related
-
2013
- 2013-01-08 ZA ZA2013/00169A patent/ZA201300169B/en unknown
- 2013-07-03 HK HK16112556.3A patent/HK1224290A1/zh unknown
- 2013-11-18 US US14/083,391 patent/US8927575B2/en not_active Expired - Fee Related
-
2014
- 2014-12-17 US US14/573,774 patent/US9162985B2/en not_active Expired - Fee Related
-
2015
- 2015-10-06 AU AU2015238774A patent/AU2015238774A1/en not_active Abandoned
-
2016
- 2016-04-11 JP JP2016078656A patent/JP2016164178A/ja active Pending
- 2016-05-20 HR HRP20160540TT patent/HRP20160540T1/hr unknown
- 2016-06-15 SM SM201600171T patent/SMT201600171B/it unknown
-
2017
- 2017-05-15 AU AU2017203236A patent/AU2017203236A1/en not_active Abandoned
- 2017-08-14 JP JP2017156436A patent/JP2017214415A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2570135T3 (es) | Sal y solvatos de un derivado de tetrahidroisoquinolina | |
NO2020018I1 (no) | Darolutamide, optionally in the form of a pharmaceutically acceptable salt or ester thereof | |
AR117799A2 (es) | Sal(es) de dimetil-amida del ácido 7-ciclopentil-2-(5-piperazin-1-il-piridin-2-il-amino)-7h-pirrolo-[2,3-d]-pirimidin-6-carboxílico y procesos para su elaboración | |
CY1122266T1 (el) | Ενωσεις 3-αμινοκυκλοαλκυλιου ως ror-gamma-t αναστολεις και χρησεις αυτων | |
LUC00083I2 (en) | Bictegravir or a pharmaceutically acceptable salt thereof, in particular bictegravir sodium | |
HK1216173A1 (zh) | -芳基取代的和 -雜芳基取代的 -羥基吡啶- -基-羰基氨基-鏈烷酸及其衍生物和其鹽,以及用相應 -羥基吡啶甲酸的衍生物進行製備的方法 | |
BR302012001940S1 (pt) | "configuração aplicada em para-choque dianteiro" | |
IL246133A0 (en) | A sulfonamide derivative or their pharmaceutically acceptable acid addition salts | |
CR20160099A (es) | Formulación de inhibidores de la syk | |
CO6680717A2 (es) | Derivados de quinolina y quinoxalina como inhibidores de cinasa | |
SG10201805628TA (en) | Deuterated heterocyclic compounds and their use as imaging agents | |
PH12015501993A1 (en) | Pyrazole-amide compound and medicinal uses therefor | |
UY34503A (es) | ?sal de bromhidrato de pridopidina? | |
MX359651B (es) | Antagonistas de cxcr7. | |
EP2881384A8 (en) | Partially saturated nitrogen-containing heterocyclic compound | |
MX343160B (es) | Dicetopiperazinas para uso en inhibir hiperpermeabilidad vascular. | |
IT1402907B1 (it) | Composizioni topiche per mantenere o ripristinare l'integrita' delle mucose. | |
IN2014DN10670A (es) | ||
IL223543A (en) | Pharmaceutical preparation containing 1– (4– (4– (4,3-dichloro-2 – fluorophenylamino) –7 – methoxyquinazoline – 6 – Iloxy) piperidine – 1 – il) Prof. 2 – an – 1 – on or a common pharmaceutical salt His and an acidic addition | |
FR2973218B1 (fr) | Plaque d'osteosynthese. | |
CO6970616A2 (es) | Composición herbicida que contiene ácido de 4-amino-3-cloro-6-(4-cloro-2-flúor -3-metoxifenil) piridina-2-carboxílico, o los derivados del mismo y fluroxipir, o los derivados del mismo | |
BR302013000613S1 (pt) | "configuração aplicada em para-choque dianteiro" | |
BRPI1014821A2 (pt) | "inibidores de replicação de hiv" | |
MX2015006223A (es) | Composiciones farmaceuticas de inhibidores cetp. | |
PH12015500012B1 (en) | Benzodioxole derivative and preparation method and use thereof |